Please, update your browser to view this website correctly. Update my browser now
O. Joannes-Boyau | M. Ranieri
Pathophysiology of lung-kidney interactions
F. Husain-Syed
ARDS and ECMO
M. Ranieri
Extracorporeal CO2 removal
M. Ranieri
Artificial organ interaction
Z. Ricci
Discussion
Break
A.T. Whaley-Connell | S. Iliceto
Heart - Kidney Interaction
C. Ronco
Emerging Cardio-renal biomarkers
A.T. Whaley-Connell
Managing hyperkalemia in CR patients
L. Di Lullo
Cardio-renal endpoints in clinical trials
A. Kazory
Discussion
H. Gomez Danies | A. Zarbock
Sepsis in 2018
J. Kellum
General management of the septic patient
M. Ostermann
Extracorporeal Therapies in Sepsis
T. Rimmelé
Sorbents in Sepsis and septic shock
C. Ronco
Discussion
Break
M. Rosner | M. Plebani
Biomarkers of Acute Kidney Injury
K. Kashani
Routine adoption of AKI biomarkers
C. Ronco
Biomarkers for clinical trials
J. Kellum
Biomarkers of progression to CKD
G. Grandaliano
Discussion
Adjourn
M. Bell | G. Grandaliano
Dose prescription in CRRT
S. Goldstein
Dose delivery versus dose prescription
P. Palevsky
Ensuring accurate fluid balance
R. Murugan
Treatment monitoring and data collection
M. Bell
Discussion
Q. Qian | P. Honoré
10 False Beliefs
Z. Ricci
Preserving circuit patency
I. Baldwin
Membrane and Filter related problems
W. Clark
Clinical complications and management
O. Joannes-Boyau
Discussion
S. Romagnoli | D.J. Askenazi
High volume HF: still indicated?
P. Honoré
Coupled Plasma Filtration Adsorption
V. Cantaluppi
High Cut off Membranes
S. Romagnoli
Polymixin-B hemoperfusion
M. Antonelli
Discussion
Break
L. Di Lullo | W. Clark
Adsorption Techniques
G. Ankawi
The hemopurifier: state of the art
S. Büttner
Ultrafiltration for heart failure
A. Kazory
Apheresis in acute patients
D.J. Askenazi
Discussion
Adjourn